Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale Women and Children's Center for Blood Disorders, New Haven, CT 06520-8063, USA.
Am J Obstet Gynecol. 2010 Oct;203(4):402.e1-4. doi: 10.1016/j.ajog.2010.06.060. Epub 2010 Aug 12.
Preimplantation factor is a novel embryo-derived peptide that influences key processes in early pregnancy implantation, including immunity, adhesion, remodeling, and apoptosis. Herein, we explore the effects of synthetic preimplantation factor on trophoblast invasion.
Invasion patterns of immortalized cultured HTR-8 trophoblast cells were analyzed through Matrigel extracellular matrix ± synthetic preimplantation factor (25-100 nM) in a transwell assay. Effects were compared with epidermal growth factor 10 μg/mL, scrambled aminoacid sequence of preimplantation factor, or media alone as controls.
Synthetic preimplantation factor enhances trophoblast invasion at physiologic doses (at 50 nM, 260%; 95% confidence interval [CI], 174-346%; P = .05; 100 nM ,178%; 95% CI, 170-184%; P < .02), compared with scrambled amnioacid sequence preimplantation factor or control media. Epidermal growth factor added to synthetic preimplantation factor does not further enhance trophoblast invasion (synthetic preimplantation factor 50 nM + epidermal growth factor, 238%; 95% CI, 237-239%; P < .03; synthetic preimplantation factor 100 nM + epidermal growth factor 269%; 95% CI, 265-273%; P < .04).
Preimplantation factor should be further investigated as it shows a potential preventative or therapeutic role for pregnancy complications associated with inadequate trophoblast invasion.
植入前因子是一种新型的胚胎衍生肽,它影响着早期妊娠植入过程中的关键过程,包括免疫、黏附、重塑和细胞凋亡。在此,我们研究了合成植入前因子对滋养层细胞侵袭的影响。
通过 Transwell 测定法,分析了永生培养的 HTR-8 滋养层细胞在 Matrigel 细胞外基质±合成植入前因子(25-100 nM)中的侵袭模式。将其与表皮生长因子 10 μg/mL、植入前因子的乱序氨基酸序列或单独培养基作为对照进行比较。
在生理剂量下(50 nM 时为 260%,95%置信区间[CI]为 174-346%,P =.05;100 nM 时为 178%,95%CI 为 170-184%,P <.02),与植入前因子的乱序氨基酸序列或对照培养基相比,合成植入前因子增强了滋养层细胞的侵袭。添加表皮生长因子到合成植入前因子中不会进一步增强滋养层细胞的侵袭(50 nM 合成植入前因子+表皮生长因子,238%,95%CI 为 237-239%,P <.03;100 nM 合成植入前因子+表皮生长因子,269%,95%CI 为 265-273%,P <.04)。
由于植入前因子显示出对与滋养层细胞侵袭不足相关的妊娠并发症的潜在预防或治疗作用,因此应进一步研究。